Erste Asset Management Gmb H Enanta Pharmaceuticals Inc Transaction History

Erste Asset Management Gmb H

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.05 - $16.54 $1.21 Million - $1.98 Million	120,000 New	120,000 $1.24 Billion
Q4 2023 Nov 26, 2024	BUY	$8.18 - $10.78 $208,590 - $274,890	25,500 Added 26.98%	120,000 $1.13 Billion
Q1 2023 Nov 26, 2024	BUY	$38.82 - $54.59 $776,400 - $1.09 Million	20,000 Added 26.85%	94,500 $3.79 Billion
Q4 2022 Nov 26, 2024	BUY	$40.77 - $53.73 $815,400 - $1.07 Million	20,000 Added 26.85%	94,500 $4.4 Billion
Q3 2022 Nov 26, 2024	SELL	$48.29 - $71.27 $2.2 Million - $3.24 Million	-45,500 Reduced 37.92%	74,500 $3.88 Billion

Q2 2022 Nov 26, 2024	SELL	$38.13 - $76.93 $1.73 Million - $3.5 Million	-45,500 Reduced 37.92%	74,500 $3.51 Billion
Q1 2022 Nov 22, 2024	BUY	$56.06 - $74.11 $4.18 Million - $5.52 Million	74,500 New	74,500 $5.25 Billion
Q4 2020 Nov 22, 2024	SELL	$41.16 - $47.47 $255,191 - $294,314	-6,200 Closed	0 $0
Q3 2020 Nov 22, 2024	SELL	$43.36 - $53.53 $4.93 Million - $6.09 Million	-113,800 Reduced 94.83%	6,200 $278 Million
Q4 2019 Nov 22, 2024	SELL	$57.95 - $66.61 $6.59 Million - $7.58 Million	-113,800 Reduced 94.83%	6,200 $388 Million
Q1 2019 Nov 22, 2024	SELL	$69.08 - $105.66 $7.86 Million - $12 Million	-113,800 Reduced 94.83%	6,200 $591 Million

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $250M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.